Search Within

Jianda Yuan

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (9)
Groups
  1. Biostatistics Service (22)
  2. Department of Medicine (22)
  3. Epidemiology and Biostatistics (22)
  4. GSK Faculty (22)
  5. Melanoma and Immunotherapeutics Service (22)
  6. Population Sciences Research Program (22)

More Groups

People
  1. Jedd Wolchok (22)
  2. Katherine Panageas (22)
  3. Teresa Rasalan (11)
  4. Humilidad Gallardo (10)
  5. Alan Houghton (9)
  6. Paul Chapman (9)

More People

Years
  1. 2020 (1)
  2. 2018 (1)
  3. 2014 (3)
  4. 2013 (3)
  5. 2012 (2)
  6. 2011 (3)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer Immunology Research (3)
  3. Journal for ImmunoTherapy of Cancer (3)
  4. Cancer Research (2)
  5. Clinical Cancer Research (2)
  6. Molecular Therapy (2)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. American Society of Clinical Oncology (4)
  3. Biomed Central Ltd (3)
  4. Lippincott Williams & Wilkins (2)
  5. Nature Publishing Group (2)
  6. Academy of Cancer Immunology (1)

More Publishers

Results (22)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab
    Journal Article

    Postow, M. A.; Chasalow, S. D.; Kuk, D.; Panageas, K. S.; Cheng, M. L.; Yuan, J.; Wolchok, J. D.
    Melanoma Research (2020)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Patterns of long-term survival following Ipilimumab (Ipi): The Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
    Meeting Abstract

    Page, D. B.; Naidoo, J.; Momtaz, P.; Bogatch, K.; Kuk, D.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Postow, M.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
    Journal Article

    Yuan, J. D.; Zhou, J.; Dong, Z.; Tandon, S.; Kuk, D.; Panageas, K. S.; Wong, P.; Wu, X. Q.; Naidoo, J.; Page, D. B.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes
    Journal Article

    Kitano, S.; Postow, M. A.; Ziegler, C. G. K.; Kuk, D.; Panageas, K. S.; Cortez, C.; Rasalan, T.; Adamow, M.; Yuan, J. D.; Wong, P.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
    Meeting Abstract

    Yuan, J.; Zhou, J.; Dong, Z.; Tandon, S.; Kuk, D.; Panageas, K. S.; Wong, P.; Wolchok, J. D.; Hodi, F. S.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Pharmacodynamic effect of ipilimumab on absolute lymphocyte count (ALC) and association with overall survival in patients with advanced melanoma
    Meeting Abstract

    Postow, M. A.; Chasalow, S. D.; Yuan, J.; Kuk, D.; Panageas, K. S.; Cheng, M.; Shahabi, V.; Berman, D. M.; Wolchok, J. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Adamow, M.; Mu, Z.; Tandon, S.; Hannaman, D.; Chapman, P.; Schwartz, G.; Carvajal, R.; Panageas, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma
    Meeting Abstract

    Kitano, S.; Postow, M. A.; Cortez, C.; Rasalan, T.; Gallardo, H. F.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Lesokhin, A. M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save